Literature DB >> 27138076

Medical Approach to the Management of Traumatized Refugees.

J David Kinzie1.   

Abstract

Refugees are a highly traumatized and culturally diverse group of patients who present many clinical challenges. Refugees have a high prevalence of traumas from torture, ethnic cleansing, and the effects of long civil wars. The most common diagnoses associated with the effects of such traumas are posttraumatic stress disorder (PTSD) or PTSD with comorbid depression; however, psychosis and neurocognitive disorders are also common. For those with PTSD, a suggested treatment approach is long-term supportive psychotherapy with drug treatment directed at reducing the most disruptive symptoms, such as insomnia, nightmares, and irritability or psychosis. The author recommends a sedative tricyclic antidepressant, clonidine or prazosin, and aripiprazole as a useful combination of medications to provide rapid relief. In addition to PTSD, long-term studies indicate a high prevalence of diabetes and hypertension in traumatized refugees. It is therefore important to perform a thorough evaluation for these disorders that includes the measurement of blood pressure and a blood test for diabetes. When managed with such a medical approach, refugees are generally accepting of psychiatric treatment and can obtain relief from the symptoms associated with the massive trauma and losses they have experienced.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27138076     DOI: 10.1097/PRA.0000000000000135

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  2 in total

1.  Posttraumatic Stress Disorder and Related Disorders among Female Yazidi Refugees following Islamic State of Iraq and Syria Attacks-A Case Series and Mini-Review.

Authors:  Inga Gerdau; Jan Ilhan Kizilhan; Michael Noll-Hussong
Journal:  Front Psychiatry       Date:  2017-12-13       Impact factor: 4.157

2.  Individual, collective, and transgenerational traumatization in the Yazidi.

Authors:  Jan Ilhan Kizilhan; Michael Noll-Hussong
Journal:  BMC Med       Date:  2017-12-11       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.